Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-09-05 Sale |
2024-09-05 7:50 pm |
Athira Pharma Inc. | ATHA | Lenington Rachel COO and CDO |
2,525 | $0.566 | $1,429 | 20,870 (Direct) |
View |
2024-01-05 Sale(A) |
2024-02-16 4:40 pm |
Athira Pharma Inc. | ATHA | Lenington Rachel COO AND CDO |
2,412 | $2.91 | $7,019 | 13,395 (Direct) |
View |
2024-01-05 Sale |
2024-01-08 4:35 pm |
Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer |
2,412 | $2.91 | $7,019 | 13,395 (Direct) |
View |
2022-06-23 Sale |
2022-06-24 7:50 pm |
Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer |
4,193 | $2.69 | $11,279 | 5,807 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-09-03 Option Award |
2024-09-05 7:50 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Lenington Rachel COO and CDO |
10,000 | $0 | 20,870 (Direct) |
View |
2024-02-14 Option Award |
2024-02-16 4:46 pm |
N/A 2034-02-13 |
Athira Pharma Inc. | ATHA | Lenington Rachel COO AND CDO |
300,000 | $0 | 300,000 (Direct) |
View |
2024-01-04 Option Award(A) |
2024-02-16 4:40 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Lenington Rachel COO AND CDO |
10,000 | $0 | 13,395 (Direct) |
View |
2024-01-04 Option Award |
2024-01-08 4:35 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer |
10,000 | $0 | 13,395 (Direct) |
View |
2023-01-19 Option Award |
2023-01-23 5:45 pm |
N/A 2033-01-18 |
Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer |
200,000 | $0 | 200,000 (Direct) |
View |
2022-06-22 Option Award |
2022-06-24 7:50 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer |
10,000 | $0 | 5,807 (Direct) |
View |
2022-01-18 Option Award |
2022-01-20 5:31 pm |
N/A 2032-01-17 |
Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer |
180,000 | $0 | 180,000 (Direct) |
View |
2021-11-03 Option Award |
2021-11-05 5:02 pm |
N/A 2031-11-02 |
Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer |
150,000 | $0 | 150,000 (Direct) |
View |
Ownership |
2021-06-14 4:58 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Lenington Rachel Chief Technology Officer |
0 | $0 | 0 (Direct) |
View |